Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
LEGN — Legend Biotech Corporation
NASDAQ
FULL STOCK PAGE →

Q3 2025 Earnings Call Summary

NOV 12, 2025
REVENUE
$272.3M +6.8%
NET MARGIN
-14.6% +34.6 PTS
EPS
-$0.21 +69.1%
FREE CASH FLOW
$23.8M +206.9%

No summary has been written for this call yet.